15 May 2020 Medicago Announces Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19
14 May 2020 INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
14 May 2020 Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
14 May 2020 CureVac´s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate
14 May 2020 VAXIMM Announces First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy VXM01 in Combination with PD-L1 Inhibitor Avelumab to be Presented at ASCO20 Virtual
12 May 2020 Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
11 May 2020 TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection
08 May 2020 ZYUS Collaborates with USask’s VIDO-InterVac to Develop a Plant-Based Vaccine for COVID-19
06 May 2020 Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
06 May 2020 OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
06 May 2020 CEPI seeks to expand COVID-19 vaccine portfolio, focusing on speed and global manufacturing
05 May 2020 Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
04 May 2020 Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
04 May 2020 Stallergenes Greer Submits a Marketing Authorisation Application in Europe for Its Sublingual House Dust Mite Allergen Immunotherapy Tablet
01 May 2020 Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
30 Apr 2020 INOVIO expands manufacturing of COVID-19 DNA vaccine INO-4800 with new funding from CEPI
30 Apr 2020 UQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials
30 Apr 2020 Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
30 Apr 2020 AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine
29 Apr 2020 Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate
29 Apr 2020 Verndari, Inc. Begins Preclinical Testing of COVID-19 Vaccine at University of California, Davis
29 Apr 2020 INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
29 Apr 2020 BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
28 Apr 2020 Shionogi Accelerates Development of Potential COVID-19 Treatments and Vaccine
28 Apr 2020 INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up